What are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? : A review of evidence under the auspices of the European Association of Urology, Female Non-Neurogenic LUTS Guidelines Panel

Farag, FawzySakalis, Vasileios I.Arteaga, Serenella MonagasSihra, NéhaKaravitakis, MarkosArlandis, SalvadorBø, KariCobussen-Boekhorst, HannyCostantini, Elisabettade Heide, MonicaGroen, JanPeyronnet, BenoitPhé, Veroniquevan Poelgeest-Pomfret, Mary Lynnevan den Bos, Tine W.L.van der Vaartq, HuubHarding, Christopher K.Lapitan, Marie Carmela M.Omar, Muhammad ImranNambiar, Arjun K.2024-05-142024-05-142023-09Farag, F, Sakalis, V I, Arteaga, S M, Sihra, N, Karavitakis, M, Arlandis, S, Bø, K, Cobussen-Boekhorst, H, Costantini, E, de Heide, M, Groen, J, Peyronnet, B, Phé, V, van Poelgeest-Pomfret, M L, van den Bos, T W L, van der Vaartq, H, Harding, C K, Lapitan, M C M, Omar, M I & Nambiar, A K 2023, 'What are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? A review of evidence under the auspices of the European Association of Urology, Female Non-Neurogenic LUTS Guidelines Panel', European Urology, vol. 84, no. 3, pp. 302-312. https://doi.org/10.1016/j.eururo.2023.05.0140302-2838ORCID: /0000-0002-1597-3126/work/143414038https://hdl.handle.net/2164/2346211286087engAnticholinergicsFemale lower urinary tracts symptomsonabotulinum toxinoveractive bladdersacral neuromodulationSystematic Reviewurgency incontinenceR MedicineRWhat are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? : A review of evidence under the auspices of the European Association of Urology, Female Non-Neurogenic LUTS Guidelines PanelJournal article10.1016/j.eururo.2023.05.014843